Arie Perry Selected Research

Cyclin-Dependent Kinase Inhibitor p16

5/2012	Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy.
3/2006	Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arie Perry Research Topics

Disease

117	Neoplasms (Cancer) 05/2024 - 01/2002
35	Meningioma (Meningiomas) 05/2024 - 05/2002
34	Glioma (Gliomas) 09/2023 - 09/2007
20	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 07/2004
19	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 12/2002
14	Neurofibrosarcoma (MPNST) 01/2020 - 02/2004
9	Brain Neoplasms (Brain Tumor) 11/2020 - 11/2004
8	Oligodendroglioma 12/2017 - 05/2003
7	Primitive Neuroectodermal Tumors (PNET) 01/2021 - 01/2006
7	Neoplasm Metastasis (Metastasis) 03/2020 - 02/2004
7	Medulloblastoma 01/2019 - 07/2004
7	Ependymoma 07/2013 - 05/2002
6	Neurilemmoma (Schwannoma) 01/2024 - 12/2005
5	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 05/2008
4	Carcinogenesis 05/2024 - 09/2010
4	Ganglioglioma 01/2022 - 09/2011
4	Necrosis 02/2015 - 03/2006
3	Disease Progression 01/2020 - 01/2006
3	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2020 - 01/2010
3	Neurofibroma 01/2017 - 12/2005
3	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2017 - 09/2007
2	Neuroblastoma 03/2024 - 03/2007
2	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 12/2023 - 12/2005
2	Hemangioma (Angioma) 01/2021 - 08/2008
2	Neurocytoma 01/2020 - 07/2004
2	Epilepsy (Aura) 10/2019 - 01/2018
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2019 - 01/2011
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2018 - 12/2017
2	Chordoma 05/2017 - 11/2014
2	Meningitis 05/2017 - 10/2016
2	Gliosarcoma 10/2016 - 05/2013
2	Monosomy 01/2016 - 05/2008
2	Typical Teratoid Rhabdoid Tumor 12/2012 - 05/2005
2	Adenocarcinoma 12/2010 - 07/2006

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2002
21	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2005
12	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 05/2002
10	RNA (Ribonucleic Acid)IBA 05/2024 - 04/2011
9	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 09/2011
9	Histones (Histone)IBA 03/2020 - 04/2013
8	Phosphotransferases (Kinase)IBA 01/2022 - 07/2009
8	ErbB Receptors (EGF Receptor)IBA 01/2021 - 12/2005
7	Neurofibromin 2 (Merlin)IBA 01/2023 - 05/2002
6	Neurofibromin 1 (Neurofibromin)IBA 01/2020 - 09/2003
5	SynaptophysinIBA 03/2024 - 03/2007
5	Transcription Factors (Transcription Factor)IBA 12/2023 - 06/2007
5	Temozolomide (Temodar)FDA LinkGeneric 12/2017 - 03/2008
4	Hormones (Hormone)IBA 01/2023 - 11/2012
4	MucinsIBA 01/2021 - 11/2004
4	AntigensIBA 12/2016 - 01/2005
4	ParaffinIBA 05/2015 - 12/2002
4	AntibodiesIBA 03/2013 - 10/2004
4	Tumor Suppressor Protein p14ARF (p14ARF)IBA 05/2012 - 11/2004
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 08/2017
3	Keratins (Keratin)IBA 01/2023 - 01/2020
3	CateninsIBA 01/2023 - 03/2011
3	Lysine (L-Lysine)FDA Link 01/2020 - 04/2013
3	2,6-dinitrotoluene (DNT)IBA 01/2020 - 01/2010
3	SteroidsIBA 10/2016 - 02/2007
3	LigandsIBA 04/2016 - 02/2004
3	Small Interfering RNA (siRNA)IBA 09/2015 - 03/2006
3	Formaldehyde (Formol)FDA Link 05/2015 - 01/2006
3	Genetic Markers (Genetic Marker)IBA 10/2014 - 11/2004
3	Cyclic AMP (AMP, Cyclic)IBA 12/2008 - 01/2007
3	OligonucleotidesIBA 03/2006 - 08/2002
2	AZD 6244IBA 01/2024 - 08/2017
2	ChromatinIBA 01/2024 - 12/2023
2	Protein Isoforms (Isoforms)IBA 12/2023 - 12/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2023 - 09/2007
2	ProlactinIBA 09/2023 - 12/2017
2	Growth Hormone (Somatotropin)IBA 09/2023 - 12/2017
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2023 - 12/2017
2	Brachyury protein (Brachyury)IBA 01/2023 - 11/2014
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 08/2017
2	tyrosine receptor (receptor, tyrosine)IBA 01/2022 - 07/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 02/2004
2	DesminIBA 01/2021 - 01/2020
2	Mutant Proteins (Protein, Mutant)IBA 12/2017 - 05/2013
2	Amylases FDA Link 08/2017 - 07/2005
2	Rituximab (Mabthera)FDA Link 10/2016 - 09/2011
2	Mucin-1 (CA 15-3 Antigen)IBA 09/2015 - 11/2004
2	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2015 - 12/2005
2	NestinIBA 08/2015 - 01/2005
2	Tumor Biomarkers (Tumor Markers)IBA 06/2015 - 08/2005
2	PlatinumIBA 09/2014 - 01/2009
2	MicroRNAs (MicroRNA)IBA 08/2014 - 12/2012
2	Bevacizumab (Avastin)FDA Link 07/2014 - 04/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 08/2008
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2013 - 01/2013
2	Complementary DNA (cDNA)IBA 11/2012 - 07/2004
2	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2012 - 03/2006
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2012 - 08/2003
2	Cadherins (E-Cadherin)IBA 09/2010 - 07/2005
2	beta CateninIBA 09/2010 - 07/2004

Therapy/Procedure

38	Therapeutics 05/2024 - 07/2004
16	Radiotherapy 05/2024 - 04/2004
11	Drug Therapy (Chemotherapy) 03/2024 - 04/2004
4	Immunotherapy 09/2023 - 11/2016
2	Neoadjuvant Therapy 01/2021 - 01/2017
2	Ventriculoperitoneal Shunt 03/2020 - 05/2017